Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.93B
Enterprise Value3.61B
P/E Ratio66.15
PEG Ratio1.28
Price/Sales Ratio7.17
Price/Book Ratio3.09
Enterprise/Revenue7.6
Enterprise/EBITDA41.94

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.05

Income Statement

Revenue1.5B
Revenue/Share7.03
Gross Profit526.71M
EBITDA307.19M
Net Income102.23M
Diluted EPS0.47

Balance Sheet

Total Cash641.51M
Total Cash/Share2.88
Total Debt1.16B
Total Debt/Equity0.49
Current Ratio1.45
Book Value Per Share11.2

Price History

52-Week Change101.59
52-Week High50.28
52-Week Low13.55
Moving Average 50 Days31.94
Moving Average 200 Days22.24

Statistics

Average Volume57.86M
Shares Outstanding339.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.16
Trailing Annual Dividend Yield0.47
Payout Ratio0.21
Last Split Factor7:5
Last Split DateJuly 09, 2026
AD